Page last updated: 2024-09-03

vadimezan and acridines

vadimezan has been researched along with acridines in 2 studies

Compound Research Comparison

Studies
(vadimezan)
Trials
(vadimezan)
Recent Studies (post-2010)
(vadimezan)
Studies
(acridines)
Trials
(acridines)
Recent Studies (post-2010) (acridines)
272161016,987169856

Protein Interaction Comparison

ProteinTaxonomyvadimezan (IC50)acridines (IC50)
AcetylcholinesteraseHomo sapiens (human)6.84

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denny, WA; Lee, HH; Li, AE; Patterson, LH; Pullen, SM; Thompson, KM; Wilson, WR1
Chiang, D; Kestell, P; Lewis, DF; Paxton, JW; Zhou, S1

Other Studies

2 other study(ies) available for vadimezan and acridines

ArticleYear
Tertiary amine N-oxides as bioreductive drugs: DACA N-oxide, nitracrine N-oxide and AQ4N.
    The British journal of cancer. Supplement, 1996, Volume: 27

    Topics: Acridines; Animals; Anthraquinones; Antineoplastic Agents; Cell Survival; Humans; Intercalating Agents; Mammary Neoplasms, Experimental; Mice; Nitracrine; Oxidation-Reduction; Prodrugs; Xanthenes; Xanthones

1996
Inhibition of human CYP1A2 oxidation of 5,6-dimethyl-xanthenone-4-acetic acid by acridines: a molecular modelling study.
    Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:8

    Topics: Acridines; Binding Sites; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Humans; Models, Molecular; Molecular Structure; Oxidation-Reduction; Structure-Activity Relationship; Xanthones

2005